| Literature DB >> 31296908 |
Florentino Huertas1, Esther Blasco2, Consuelo Moratal2, Juan Lupiañez3.
Abstract
Consume of stimulants (as caffeine) is very usual in different contexts where the performers have to take quick and accurate decisions during physical effort. Decision-making processes are mediated by the attentional networks. An experiment was carried out to examine the effect of caffeine intake on attention (alerting, orienting, and executive control) as a function of consumption habit under two physical exertion conditions (rest vs. aerobic exercise). Two groups of participants with different caffeine consumption profiles (moderate consumers vs. low consumers) performed the Attention Network Test-Interactions under four different conditions regarding activity (rest vs. exercise) and intake (caffeine vs. placebo). Results showed that whereas exercise led to faster reaction times (RT) in all cases, caffeine intake accelerated RT but only at rest and in moderate caffeine consumers. More importantly, caffeine intake reduced the alertness effect in moderate consumers only at the rest condition. No interactions between Intake and Activity were observed in the other attentional networks, with exercise reducing orienting independently of caffeine intake, which suggests that physical exercise and caffeine are different modulators of attention but can interact. Caffeine intake had differential effects on reaction speed at rest and during physical exercise depending on the individual consumption habit. On the basis of these finding it seems that mainly alertness is modulated differently by internal and external "arousing" conditions.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31296908 PMCID: PMC6624295 DOI: 10.1038/s41598-019-46524-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic representation of the experimental protocol timing.
Figure 2Procedure of the ANT-I task.
Anthropometric and physiological characteristics according to participant group.
| Variables | Mean ± | All | |
|---|---|---|---|
| Low consumers | Moderate consumers | ||
| Age (years) | 21.9 ± 1.9 | 22.9 ± 3.9 | 22.4 ± 3.0 |
| Weight (kg) | 74.6 ± 6.5 | 72.9 ± 11.1 | 73.7 ± 9.0 |
| Height (cm) | 178.2 ± 4.6 | 178.8 ± 5.7 | 178.5 ± 5.1 |
| HR baseline (bpm) | 64 ± 6 | 67 ± 8 | 66 ± 7 |
| Predicted HRmax (bpm) | 177 ± 3 | 183 ± 2 | 180 ± 2 |
| HR at LT (bpm) | 150 ± 13 | 155 ± 9 | 155 ± 11 |
| LT (mmol · L−1) | 3.6 ± 0.8 | 3.6 ± 0.7 | 3,6 ± 0.8 |
| Workload at LT (W) | 173.6 ± 28.0 | 160.0 ± 22.1 | 166.5 ± 25.5 |
Note. SD = standard deviation; HR = heart rate; LT = lactate threshold; bpm = beats per minute; W = watts; mmol · L−1: millimoles per liter; HRmax = maximum predicted heart rate.
Mean (M) ± SD values of workload and physiological response values to each Activity and Intake experimental condition according to participants’ caffeine consumption habit.
| Variables | Rest | Exercise | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caffeine | Placebo | Caffeine | Placebo | |||||||||
| Low | Moderate | All | Low | Moderate | All | Low | Moderate | All | Low | Moderate | All | |
| Workload (W) | — | — | — | — | — | — | 106.3 ± 19.3 | 104.7 ± 19.6 | 105.5 ± 19.0 | 106.7 ± 23.6 | 101.5 ± 18.1 | 104.0 ± 20.6 |
| Initial [La−] (mmol · L−1) | — | — | — | — | — | — | 2.5 ± 0.9 | 2.4 ± 1.1 | 2.4 ± 1.0 | 2.2 ± 0.7 | 2.3 ± 0.8 | 2.3 ± 0.7 |
| Final [La−] (mmol · L−1) | — | — | — | — | — | — | 2.0 ± 0.9 | 2.4 ± 0.8 | 2.2 ± 0.8 | 1.9 ± 0.8 | 2.2 ± 0.7 | 2.1 ± 0.7 |
| HR (bpm) | 67 ± 8 | 70 ± 11 | 68 ± 9 | 64 ± 6 | 67 ± 8 | 65 ± 7 | 120 ± 9 | 126 ± 8 | 122 ± 8 | 121 ± 7 | 126 ± 9 | 123 ± 8 |
| % predicted HRmax | 38.5 ± 5.2 | 38.2 ± 6.0 | 38.3 ± 5.6 | 36.2 ± 4.1 | 37.7 ± 5.4 | 36.5 ± 4.0 | 68.6 ± 4.0 | 69.2 ± 3.7 | 68.7 ± 4.5 | 68.6 ± 4.8 | 69.3 ± 3.3 | 68.8 ± 4.1 |
| % HR at LT | 44.1 ± 5.2 | 45.5 ± 4.0 | 44.7 ± 5.3 | 43.6 ± 5.4 | 43.8 ± 4.6 | 43.7 ± 5.3 | 80.2 ± 4.0 | 85.3 ± 4.3 | 82.3 ± 4.1 | 80.3 ± 4.1 | 85.2 ± 4.3 | 82.6 ± 4.1 |
Note. Note that under Rest condition the Workload and Lactate values were -, because no work was developed and the instrument used to measure Lactate concentration does not give values below 0.8. SD = standard deviation; HR = heart rate; HRmax = maximum predicted heart rate; LT = lactate threshold; bpm = beats per minute; W = watts; mmol · L−1: millimoles per liter.
Mean Reaction Time and error percentage (in parenthesis) for each experimental condition and for each consumption habit group.
| Low Consumers | Moderate Consumers | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Tone | Tone | No Tone | Tone | |||||||||||
| Uncued | No Cue | Cued | Uncued | No Cue | Cued | Uncued | No Cue | Cued | Uncued | No Cue | Cued | |||
| Exercise | Caffeine Intake | Congruent | 451 | 467 | 428 | 445 | 427 | 422 | 455 | 470 | 440 | 441 | 429 | 414 |
| (0.00%) | (0.69%) | (0.17%) | (0.35%) | (0.69%) | (0.00%) | (0.00%) | (0.35%) | (0.00%) | (0.35%) | (0.35%) | (0.00%) | |||
| Incongruent | 520 | 490 | 480 | 533 | 497 | 474 | 532 | 530 | 505 | 540 | 508 | 482 | ||
| (6.42%) | (1.39%) | (1.74%) | (5.90%) | (2.78%) | (2.43%) | (5.56%) | (2.08%) | (1.04%) | (5.56%) | (2.43%) | (1.04%) | |||
| Placebo Intake | Congruent | 445 | 464 | 426 | 446 | 429 | 410 | 456 | 468 | 432 | 441 | 432 | 414 | |
| (0.69%) | (0.69%) | (0.69%) | (0.52%) | (0.69%) | (0.17%) | (1.04%) | (0.69%) | (0.00%) | (0.35%) | (0.35%) | (0.00%) | |||
| Incongruent | 524 | 517 | 495 | 535 | 495 | 481 | 540 | 523 | 502 | 532 | 500 | 481 | ||
| (3.30%) | (3.30%) | (2.26%) | (6.77%) | (1.91%) | (4.34%) | (2.43%) | (4.51%) | (2.43%) | (7.29%) | (2.43%) | (3.13%) | |||
| Rest | Caffeine Intake | Congruent | 505 | 509 | 460 | 496 | 472 | 456 | 496 | 500 | 468 | 484 | 462 | 447 |
| (0.17%) | (0.52%) | (0.00%) | (0.35%) | (0.00%) | (0.00%) | (0.00%) | (0.69%) | (0.00%) | (0.35%) | (0.00%) | (0.00%) | |||
| Incongruent | 581 | 559 | 520 | 585 | 542 | 510 | 586 | 565 | 530 | 591 | 546 | 510 | ||
| (3.30%) | (0.87%) | (0.52%) | (5.03%) | (2.43%) | (0.87%) | (2.43%) | (1.04%) | (0.35%) | (5.21%) | (2.43%) | (1.04%) | |||
| Placebo Intake | Congruent | 493 | 510 | 466 | 488 | 473 | 456 | 536 | 547 | 508 | 520 | 490 | 486 | |
| (0.17%) | (0.17%) | (0.17%) | (0.00%) | (0.35%) | (0.35%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.35%) | |||
| Incongruent | 576 | 555 | 528 | 580 | 536 | 511 | 631 | 620 | 565 | 615 | 567 | 544 | ||
| (2.26%) | (2.26%) | (1.39%) | (4.51%) | (2.26%) | (2.43%) | (1.74%) | (2.78%) | (1.04%) | (2.78%) | (2.43%) | (2.43%) | |||
Figure 3Mean RT as a function of Activity and Caffeine intake for each group of Consumption habit. Note: ***p < 0.005.
Figure 4Attentional index of the functioning of each attentional network, as a function of Activity, Caffeine intake and Consum Habit (top panel: Low caffeine consumers; bottom panel: Moderate caffeine consumers). Alertness index = RT No Tone – RT Tone trials (exclusively on No cue trials). Orienting index = RT Uncued – RT Cued trials. Control index (interference) = RT Incongruent – RT Congruent trials. Note: *p < 0.05.